Table 3.
a. Agreement between TST and IFN-γ | ||
---|---|---|
Test Results | 5mm | 10mm |
Positive TST/Positive QFT-IT | 27 | 25 |
Negative TST/Negative QFT-IT | 106 | 110 |
Positive TST/Negative QFT-IT | 6 | 2 |
Negative TST/Positive QFT-IT | 41 | 43 |
Agreement % | 73.9% | 75% |
k (95% CI) | 0.38 (0.23–0.53) | 0.40 (0.24–0.55) |
b. Agreement between TST and IP-10 | ||
---|---|---|
Test Results | 5mm | 10mm |
Positive TST/Positive IP-10 | 25 | 22 |
Negative TST/Negative IP-10 | 89 | 91 |
Positive TST/Negative IP-10 | 5 | 3 |
Negative TST/Positive IP-10 | 51 | 54 |
Agreement % | 67.1 | 66.5 |
k (95% CI) | 0.29 (0.14–0.44) | 0.28 (0.12–0.43) |
c. Agreement between IFN-γ and IP-10 | ||||
---|---|---|---|---|
Tests | IP-10 | |||
QFT-IT | Positive | Negative | Total | |
Positive | 56 | 8 | 64 | |
Negative | 20 | 86 | 106 | |
Total | 76 | 94 | 170 | |
Agreement % | 83.5 | |||
K (95% CI) | 0.66 (0.55–0.78) |
QFT-IT - QuantiFERON TB-Gold in-tube
IP-10 – Interferon gamma inducible protein-10
TST- Tuberculin Skin test
CI – Confidence interval
k – kappa
% - Percentage